Brazilian pharmaceutical manufacturer focused on anesthetics and open-innovation drug development
Laboratório Cristália is a domestically-owned chemical-pharmaceutical company operating at scale (5,001–10,000 employees) from Itapira, São Paulo, since 1972. The hiring mix is heavily skewed toward manufacturing and research roles, with upstream process optimization appearing across both active projects and stated pain points—signaling ongoing investment in production scaling and biotech capability. Their tech stack is enterprise-standard (SAP, Oracle Primavera, BI tools) with no visible cutting-edge adoption, typical of legacy manufacturing operations.
Cristália manufactures and distributes pharmaceuticals across Latin America, with particular strength in anesthetics and anesthesia adjuvants. The company positions itself around three operational pillars: innovation, quality, and fair pricing. In recent years, leadership has shifted toward open-innovation partnerships with academic research centers, translating university discoveries into market-ready drugs. Current project portfolio centers on upstream process scaling, bioproduct industrialization, tax optimization, and compliance with good manufacturing practice (BPF) standards. Manufacturing and research teams comprise the largest hiring segments.
Cristália manufactures and markets anesthetics and anesthesia adjuvants, serving Latin American markets. Founded in 1972 in Itapira, São Paulo, it employs 5,001–10,000 people and operates as a privately-held, Brazilian-owned firm.
Core systems include SAP, SAP S/4HANA, Oracle Primavera, Power BI, and Microsoft Project for ERP, project management, and analytics. No recent major tech migrations or modern-stack adoptions are visible in current data.
Other companies in the same industry, closest in size